1. Home
  2. JAZZ vs NWS Comparison

JAZZ vs NWS Comparison

Compare JAZZ & NWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$208.12

Market Cap

16.1B

Sector

Health Care

ML Signal

HOLD

Logo News Corporation Class B

NWS

News Corporation Class B

HOLD

Current Price

$32.95

Market Cap

17.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAZZ
NWS
Founded
2003
2012
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
16.1B
17.9B
IPO Year
2007
2012

Fundamental Metrics

Financial Performance
Metric
JAZZ
NWS
Price
$208.12
$32.95
Analyst Decision
Buy
Analyst Count
22
0
Target Price
★ $294.64
N/A
AVG Volume (30 Days)
715.2K
★ 839.4K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
★ 0.61%
EPS Growth
N/A
★ N/A
EPS
★ 7.17
1.03
Revenue
$1,618,693,000.00
★ $9,028,000,000.00
Revenue This Year
$10.65
$4.24
Revenue Next Year
$5.76
$3.48
P/E Ratio
★ $29.35
$31.94
Revenue Growth
N/A
★ 6.81
52 Week Low
$128.80
$25.49
52 Week High
$266.38
$35.76

Technical Indicators

Market Signals
Indicator
JAZZ
NWS
Relative Strength Index (RSI) 26.18 53.28
Support Level $194.77 $32.49
Resistance Level $241.39 $32.91
Average True Range (ATR) 6.94 0.54
MACD -1.78 0.17
Stochastic Oscillator 4.51 68.88

Price Performance

Historical Comparison
JAZZ
NWS

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About NWS News Corporation Class B

News Corporation is a diversified media and information services conglomerate with significant presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

Share on Social Networks: